These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37089865)

  • 41. Validation of claims-based algorithms for pulmonary arterial hypertension.
    Papani R; Sharma G; Agarwal A; Callahan SJ; Chan WJ; Kuo YF; Shim YM; Mihalek AD; Duarte AG
    Pulm Circ; 2018; 8(2):2045894018759246. PubMed ID: 29480064
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Song J; Hinderhofer K; Kaufmann LT; Benjamin N; Fischer C; Grünig E; Eichstaedt CA
    Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33036198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
    Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
    Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension.
    Simpson CE; Ambade AS; Harlan R; Roux A; Aja S; Graham D; Shah AA; Hummers LK; Hemnes AR; Leopold JA; Horn EM; Berman-Rosenzweig ES; Grunig G; Aldred MA; Barnard J; Comhair SAA; Tang WHW; Griffiths M; Rischard F; Frantz RP; Erzurum SC; Beck GJ; Hill NS; Mathai SC; Hassoun PM; Damico RL;
    Am J Physiol Lung Cell Mol Physiol; 2023 Nov; 325(5):L617-L627. PubMed ID: 37786941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.
    Allen RJ; Porte J; Braybrooke R; Flores C; Fingerlin TE; Oldham JM; Guillen-Guio B; Ma SF; Okamoto T; John AE; Obeidat M; Yang IV; Henry A; Hubbard RB; Navaratnam V; Saini G; Thompson N; Booth HL; Hart SP; Hill MR; Hirani N; Maher TM; McAnulty RJ; Millar AB; Molyneaux PL; Parfrey H; Rassl DM; Whyte MKB; Fahy WA; Marshall RP; Oballa E; Bossé Y; Nickle DC; Sin DD; Timens W; Shrine N; Sayers I; Hall IP; Noth I; Schwartz DA; Tobin MD; Wain LV; Jenkins RG
    Lancet Respir Med; 2017 Nov; 5(11):869-880. PubMed ID: 29066090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.
    Duarte AG; Lin YL; Sharma G
    J Heart Lung Transplant; 2017 Feb; 36(2):220-226. PubMed ID: 27595194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling. Transcriptional Regulation by SOX and HIF-2α.
    Sun X; Sun BL; Babicheva A; Vanderpool R; Oita RC; Casanova N; Tang H; Gupta A; Lynn H; Gupta G; Rischard F; Sammani S; Kempf CL; Moreno-Vinasco L; Ahmed M; Camp SM; Wang J; Desai AA; Yuan JX; Garcia JGN
    Am J Respir Cell Mol Biol; 2020 Jul; 63(1):92-103. PubMed ID: 32142369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension.
    Lian G; You J; Lin W; Gao G; Xu C; Wang H; Luo L
    BMC Pulm Med; 2023 Aug; 23(1):300. PubMed ID: 37582718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
    Kudryashova TV; Dabral S; Nayakanti S; Ray A; Goncharov DA; Avolio T; Shen Y; Rode A; Pena A; Jiang L; Lin D; Baust J; Bachman TN; Graumann J; Ruppert C; Guenther A; Schmoranzer M; Grobs Y; Eve Lemay S; Tremblay E; Breuils-Bonnet S; Boucherat O; Mora AL; DeLisser H; Zhao J; Zhao Y; Bonnet S; Seeger W; Pullamsetti SS; Goncharova EA
    Circ Res; 2022 Mar; 130(5):760-778. PubMed ID: 35124974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
    Redel-Traub G; Sampson KJ; Kass RS; Bohnen MS
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pathophysiological role of novel pulmonary arterial hypertension gene
    Wu Y; Wharton J; Walters R; Vasilaki E; Aman J; Zhao L; Wilkins MR; Rhodes CJ
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 33632800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel
    Pienkos S; Gallego N; Condon DF; Cruz-Utrilla A; Ochoa N; Nevado J; Arias P; Agarwal S; Patel H; Chakraborty A; Lapunzina P; Escribano P; Tenorio-Castaño J; de Jesús Pérez VA
    Front Med (Lausanne); 2021; 8():625763. PubMed ID: 33996849
    [No Abstract]   [Full Text] [Related]  

  • 53. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension.
    Chen JY; Griffiths M; Yang J; Nies MK; Damico RL; Simpson CE; Vaidya RD; Brandal S; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Rosenzweig EB; Hirsch R; Yung D; Everett AD
    J Pediatr; 2020 Aug; 223():164-169.e1. PubMed ID: 32711743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An emerging phenotype of pulmonary arterial hypertension patients carrying
    Montani D; Lechartier B; Girerd B; Eyries M; Ghigna MR; Savale L; Jaïs X; Seferian A; Jevnikar M; Boucly A; Riou M; Traclet J; Chaouat A; Levy M; Le Pavec J; Fadel E; Perros F; Soubrier F; Remy-Jardin M; Sitbon O; Bonnet D; Humbert M
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35618278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Description of Two New Cases of
    Gallego-Zazo N; Cruz-Utrilla A; Del Cerro MJ; Ochoa Parra N; Blanco JN; Arias P; Lapunzina P; Escribano-Subias P; Tenorio-Castaño J
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
    Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
    Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study.
    Yuan Y; Li S; Yan M; Yang Y; Zhong C; Hu Y
    BMC Pulm Med; 2024 May; 24(1):235. PubMed ID: 38745167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrative Multiomics to Dissect the Lung Transcriptional Landscape of Pulmonary Arterial Hypertension.
    Hong J; Wong B; Rhodes CJ; Kurt Z; Schwantes-An TH; Mickler EA; Gräf S; Eyries M; Lutz KA; Pauciulo MW; Trembath RC; Montani D; Morrell NW; Wilkins MR; Nichols WC; Trégouët DA; Aldred MA; Desai AA; Tuder RM; Geraci MW; Eghbali M; Stearman RS; Yang X
    bioRxiv; 2023 Jan; ():. PubMed ID: 36712057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension.
    Farha S; Hu B; Comhair S; Zein J; Dweik R; Erzurum SC; Aldred MA
    PLoS One; 2016; 11(5):e0156042. PubMed ID: 27224443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.